StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific tổng số phê duyệt FDA PMA & Supplements toàn ngành tại Hoa Kỳ (U.S. Industry Total)

U.S. FDA openFDA Premarket Approval (PMA) API

QuarterlyAnnualMonthly
Latest, Q3 2026
565
Period ended Sep 30, 2026
Change on a year earlier
-3.4%
585 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTổng số phê duyệt FDA PMA & Supplements toàn ngành tại Hoa Kỳ (U.S. Industry Total)Year on yearSource
Q3 2026Sep 30, 2026565-3.4%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q2 2026Jun 30, 2026608+3.4%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q1 2026Mar 31, 2026567+8.2%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q4 2025Dec 31, 2025525-23.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q3 2025Sep 30, 2025585+8.7%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q2 2025Jun 30, 2025588+6.9%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q1 2025Mar 31, 2025524+14.2%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q4 2024Dec 31, 2024683+4.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q3 2024Sep 30, 2024538-1.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q2 2024Jun 30, 2024550-1.4%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q1 2024Mar 31, 2024459+7.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q4 2023Dec 31, 2023656+11.9%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q3 2023Sep 30, 2023544+11.2%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q2 2023Jun 30, 2023558+16.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q1 2023Mar 31, 2023427-20.6%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Q4 2022Dec 31, 2022586+2.6%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Tổng số phê duyệt FDA PMA & Supplements toàn ngành tại Hoa Kỳ (U.S. Industry Total), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda_pma_industry

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.